Patents Assigned to The Board of Regents of the University of Oklahoma System
  • ALTERTOXIN II AS A SELECTIVE INHIBITOR OF EWING FAMILY OF TUMOR CELLS
    Publication number: 20200101038
    Abstract: Certain embodiments are directed to methods for treating Ewing family tumors (EFT) comprising administering an effective amount of altertoxin II to a subject having EFT.
    Type: Application
    Filed: December 20, 2017
    Publication date: April 2, 2020
    Applicants: The Board of Regents of the University of Texas System, The Board of Regents of the University of Oklahoma System
    Inventors: Susan L MOOBERRY, Andrew J ROBLES, April L RISINGER, Robert H CICHEWICZ, Salkat HALDAR, Peter HOUGHTON